Use of the Response Assessment in Neuro-Oncology (RANO) criteria in clinical trials and clinical practice

Ugonma N Chukwueke; Patrick Y Wen

doi:10.2217/cns-2018-0007

Use of the Response Assessment in Neuro-Oncology (RANO) criteria in clinical trials and clinical practice

CNS Oncol. 2019 Mar 1;8(1):CNS28. doi: 10.2217/cns-2018-0007. Epub 2019 Feb 26.

Authors

Ugonma N Chukwueke^{1

2}, Patrick Y Wen^{1

2}

Affiliations

¹ Department of Medical Oncology, Center for Neuro-Oncology, Dana-Farber Cancer Institute, Boston, MA, 02215, USA.
² Department of Neurology, Harvard Medical School, 450 Brookline Avenue, Boston, MA, 02215, USA.

No abstract available

Keywords: CNS tumors; RANO; bevacizumab; clinical trials; immune checkpoint inhibitors; pediatric brain tumor imaging; pseudoprogresion; pseudoresponse; response criteria.

Publication types

Review

MeSH terms

Central Nervous System Neoplasms / diagnosis*
Central Nervous System Neoplasms / therapy*
Clinical Trials as Topic*
Humans
Practice Patterns, Physicians'*
Treatment Outcome